Dual Targeting Fixed-Duration Front-Line Monoclonal Antibody Therapy for CLL
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Leukemia Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dual targeting fixed duration frontline monoclonal antibody therapy for chronic lymphocytic leukemia: A phase 2 study
Leuk. Res 2022 Sep 05;122(xx)106945, S Ma, ST Rosen, M Winqvist, O Frankfurt, JN Winter, L Gordon, I Helenowski, H Zhang, J Kreutzer, S Sönnert-Husa, A Österborg, J LundinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.